Heron Therapeutics Inc (HRTX)

SG&A Expense Growth

-3.84%

Quarterly · Period ending:

HRTX logo

HRTX SG&A Expense Growth

Latest reported-3.84%
HRTX Quarterly SG&A Growth (QoQ) (0.00% → -3.84%)
High-resolution chart · PNG

HRTX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-3.8446%
2.9901%
-4.5948%
3.3633%
4.1299%
7.8054%
-0.6126%
-15.1677%
4.1755%
11.8469%
-3.9802%
-39.7088%
10.2979%
38.537%
-5.2454%
-12.2731%
-2.5368%
-4.1281%
-1.7661%
5.5343%
33.6491%
-11.5733%
27.5447%
-13.4249%
-17.0161%
1.0695%
18.4562%
-23.4884%
-12.8831%
33.7097%
21.7489%
13.6403%
-0.5896%
-8.6879%
14.2914%
-4.6003%
14.1278%
-0.9762%
6.0027%
10.8492%
-8.3624%
16.3749%
79.3576%
20.6317%
16.7862%
-16.5336%
66.1772%
-3.2539%
-21.3835%
30.9507%
-37.4687%
44.9124%
-21.7726%
65.8807%
48.4761%
84.92%
-8.8194%
14.0143%
8.8793%
127.8978%
-10.5448%
38.7805%
-7.8652%
-80.9422%
198.9757%
-2.6185%
-12.0614%
-14.4465%
14.9946%
-15.1099%
-14.1509%
47.3928%
-20.0926%
23.2877%
14.9606%
-12.6147%
-22.0036%
19.8285%
12.4096%
-11.0397%
0.1073%
-9.0732%
18.0876%
5.4678%
-3.0624%
-13.3673%
28.9474%
-0.2625%
5.2486%
19.2751%
-6.4715%
-15.2742%
-1.5424%
-15.2505%
14.1791%
-14.1942%
11.9696%
4.8721%
-3.4146%
-4.4631%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.